Home › Companies › JAZZ PHARMACEUTICALS PLC › 2023-2024

JAZZ PHARMACEUTICALS PLC 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated 02 October 2026.

15Reported items
556Asset managers
4,950Fund votes
2023-08-03Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore JAZZ PHARMACEUTICALS PLC in the interactive database Compare manager voting policies

How asset managers voted at the JAZZ PHARMACEUTICALS PLC 2023-2024 meeting

Each item below shows how the 556 asset managers that disclosed a JAZZ PHARMACEUTICALS PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of JAZZ PHARMACEUTICALS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2023-08-03; no official results are on file for this meeting.

Combines 16 wordings of this item as funds reported it.

94% fund support · no official result

FOR 94%

The 503 asset managers below cast 94% of the shares they voted on this item FOR (49,338,541 for, 3,235,960 against).

FOR: 49,338,541 (93.8%)AGAINST: 3,235,960 (6.2%)ABSTAIN: 25,053 (0.0%)NOT VOTED: 1,202 (0.0%)NO VOTE: 264 (0.0%)

Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive of” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Vote
BlackRock	6,298,719	501	For
Vanguard	6,193,152	0	For
Fidelity	3,136,956	0	For
State Street	2,331,436	0	For
LSV ASSET MANAGEMENT	1,611,612	24,710	For
JPMorgan	1,581,518	0	For
Wellington	1,521,731	0	For
FRANKLIN ADVISERS INC	1,213,833	0	For
Deep Track Capital, LP	1,200,000	0	For
Swedbank Robur Fonder AB	0	1,069,994	Against
Hartford	1,008,322	0	For
Columbia Threadneedle	982,325	0	For
GEODE CAPITAL MANAGEMENT, LLC	965,106	0	For
Charles Schwab	916,266	0	For
SAMLYN CAPITAL, LLC	818,354	0	For
Dimensional	783,552	0	For
BNP Paribas Asset Management Holding S.A.	0	718,434	Against
MELLON INVESTMENTS Corp	667,248	0	For
Baupost	622,696	0	For
Avidity Partners Management LP	551,400	0	For
Prudential/PGIM	528,624	0	For
Pacer Funds Trust	489,682	0	For
Invesco	483,535	0	For
Renaissance	478,117	0	For
SEI	462,852	8,912	For

Showing the 25 largest of 503 asset managers. See all 503 in the interactive database.

2. To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Anne O'Riordan

DIRECTOR ELECTIONS

Meeting held 2023-08-03; no official results are on file for this meeting.

Combines 9 wordings of this item as funds reported it.

99.2% fund support · no official result

FOR 99.1%

The 129 asset managers below cast 99.2% of the shares they voted on this item FOR (22,418,993 for, 170,413 against).

FOR: 22,418,993 (99.1%)AGAINST: 170,413 (0.8%)ABSTAIN: 25,047 (0.1%)

Largest asset managers voting on “To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareh” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Vote
Vanguard	6,038,823	For
BlackRock	3,454,854	For
Fidelity	1,937,711	For
JPMorgan	1,487,735	For
Hartford	1,008,293	For
Columbia Threadneedle	976,745	For
Dimensional	612,817	For
Pacer Funds Trust	489,682	For
FRANKLIN STRATEGIC SERIES	461,963	For
Prudential/PGIM	460,752	For
Charles Schwab	456,965	For
Pear Tree Funds	416,700	For
State Street	392,374	For
Jackson National	263,130	For
TIAA	255,251	For
JANUS INVESTMENT FUND	247,291	For
John Hancock	218,680	For
Invesco	217,460	For
SEI	199,796	For
Russell Investments	192,236	For
Bridge Builder Trust	179,717	For
AIG/SunAmerica	150,578	For
Franklin Custodian Funds	150,000	For
Northwestern Mutual	144,818	For
Equitable	123,217	For

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

3. To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Bruce C. Cozadd

DIRECTOR ELECTIONS

Meeting held 2023-08-03; no official results are on file for this meeting.

Combines 8 wordings of this item as funds reported it.

99.7% fund support · no official result

FOR 99.6%

The 129 asset managers below cast 99.7% of the shares they voted on this item FOR (22,534,687 for, 54,719 against).

FOR: 22,534,687 (99.6%)AGAINST: 54,719 (0.2%)ABSTAIN: 25,047 (0.1%)

Largest asset managers voting on “To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareh” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Vote
Vanguard	6,038,823	0	For
BlackRock	3,454,854	0	For
Fidelity	1,937,711	0	For
JPMorgan	1,487,735	0	For
Hartford	1,008,293	0	For
Columbia Threadneedle	976,745	0	For
Dimensional	612,817	0	For
Pacer Funds Trust	489,682	0	For
FRANKLIN STRATEGIC SERIES	461,963	0	For
Prudential/PGIM	460,752	0	For
Charles Schwab	456,965	0	For
Pear Tree Funds	416,700	0	For
State Street	392,374	0	For
Jackson National	263,130	0	For
TIAA	255,251	0	For
JANUS INVESTMENT FUND	247,291	0	For
John Hancock	218,680	0	For
Invesco	217,460	0	For
SEI	199,796	0	For
Russell Investments	192,236	0	For
Bridge Builder Trust	175,088	4,629	For
AIG/SunAmerica	150,578	0	For
Franklin Custodian Funds	150,000	0	For
Northwestern Mutual	144,818	0	For
Equitable	123,217	0	For

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

4. To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Heather Ann McSharry

DIRECTOR ELECTIONS

Meeting held 2023-08-03; no official results are on file for this meeting.

Combines 8 wordings of this item as funds reported it.

96% fund support · no official result

FOR 96%

The 129 asset managers below cast 96% of the shares they voted on this item FOR (21,725,733 for, 863,673 against).

FOR: 21,725,733 (96.1%)AGAINST: 863,673 (3.8%)ABSTAIN: 25,047 (0.1%)

Largest asset managers voting on “To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareh” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Vote
Vanguard	6,038,823	0	For
BlackRock	3,454,854	0	For
Fidelity	1,937,711	0	For
JPMorgan	1,487,735	0	For
Hartford	1,008,293	0	For
Columbia Threadneedle	976,745	0	For
Dimensional	612,817	0	For
Pacer Funds Trust	489,682	0	For
FRANKLIN STRATEGIC SERIES	461,963	0	For
Prudential/PGIM	460,752	0	For
Charles Schwab	456,965	0	For
Pear Tree Funds	416,700	0	For
State Street	392,374	0	For
Jackson National	263,130	0	For
TIAA	0	255,251	Against
JANUS INVESTMENT FUND	247,291	0	For
John Hancock	218,680	0	For
Invesco	0	217,460	Against
SEI	199,796	0	For
Russell Investments	192,236	0	For
Bridge Builder Trust	179,717	0	For
AIG/SunAmerica	150,578	0	For
Franklin Custodian Funds	150,000	0	For
Northwestern Mutual	144,818	0	For
Equitable	36,764	86,453	Against

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

5. To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Rick E. Winningham

DIRECTOR ELECTIONS

Meeting held 2023-08-03; no official results are on file for this meeting.

Combines 8 wordings of this item as funds reported it.

99.1% fund support · no official result

FOR 99.0%

The 129 asset managers below cast 99.1% of the shares they voted on this item FOR (22,406,041 for, 183,365 against).

FOR: 22,406,041 (99.1%)AGAINST: 183,365 (0.8%)ABSTAIN: 25,047 (0.1%)

Largest asset managers voting on “To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareh” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Vote
Vanguard	6,038,823	0	For
BlackRock	3,454,854	0	For
Fidelity	1,937,711	0	For
JPMorgan	1,487,735	0	For
Hartford	1,008,293	0	For
Columbia Threadneedle	976,745	0	For
Dimensional	612,817	0	For
Pacer Funds Trust	489,682	0	For
FRANKLIN STRATEGIC SERIES	461,963	0	For
Prudential/PGIM	460,752	0	For
Charles Schwab	456,965	0	For
Pear Tree Funds	416,700	0	For
State Street	392,374	0	For
Jackson National	263,130	0	For
TIAA	255,251	0	For
JANUS INVESTMENT FUND	247,291	0	For
John Hancock	218,680	0	For
Invesco	217,460	0	For
SEI	199,796	0	For
Russell Investments	192,236	0	For
Bridge Builder Trust	175,088	4,629	For
AIG/SunAmerica	150,578	0	For
Franklin Custodian Funds	150,000	0	For
Northwestern Mutual	144,818	0	For
Equitable	123,217	0	For

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

6. To approve any motion to adjourn the Annual General Meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the Annual General Meeting to approve Proposal 4.

CORPORATE GOVERNANCE

Meeting held 2023-08-03; no official results are on file for this meeting.

Combines 5 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 127 asset managers below cast 98% of the shares they voted on this item FOR (22,104,184 for, 445,278 against).

FOR: 22,104,184 (97.9%)AGAINST: 445,278 (2.0%)ABSTAIN: 25,047 (0.1%)

Largest asset managers voting on “To approve any motion to adjourn the Annual General Meeting, or any adjournments thereof, to another time and ” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Vote
Vanguard	6,038,823	0	For
BlackRock	3,454,854	0	For
Fidelity	1,937,711	0	For
JPMorgan	1,487,735	0	For
Hartford	1,008,293	0	For
Columbia Threadneedle	976,745	0	For
Dimensional	612,817	0	For
Pacer Funds Trust	489,682	0	For
FRANKLIN STRATEGIC SERIES	461,963	0	For
Prudential/PGIM	458,302	2,450	For
Charles Schwab	456,965	0	For
Pear Tree Funds	416,700	0	For
State Street	0	392,374	Against
Jackson National	263,130	0	For
TIAA	255,251	0	For
JANUS INVESTMENT FUND	247,291	0	For
John Hancock	218,680	0	For
Invesco	217,460	0	For
SEI	192,477	7,319	For
Russell Investments	192,236	0	For
Bridge Builder Trust	175,088	4,629	For
AIG/SunAmerica	150,578	0	For
Franklin Custodian Funds	150,000	0	For
Northwestern Mutual	144,818	0	For
Equitable	123,217	0	For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

7. To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharmaceuticals plc for the fiscal year ending December 31, 2023 and to authorize, in a binding vote, the Board of Directors, acting through the audit committee, to determine KPMG's remuneration.

AUDIT-RELATED

Meeting held 2023-08-03; no official results are on file for this meeting.

Combines 6 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.8%

The 127 asset managers below cast 99.9% of the shares they voted on this item FOR (22,541,303 for, 8,159 against).

FOR: 22,541,303 (99.9%)AGAINST: 8,159 (0.0%)ABSTAIN: 25,047 (0.1%)

Largest asset managers voting on “To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharma” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Vote
Vanguard	6,038,823	For
BlackRock	3,454,854	For
Fidelity	1,937,711	For
JPMorgan	1,487,735	For
Hartford	1,008,293	For
Columbia Threadneedle	976,745	For
Dimensional	612,817	For
Pacer Funds Trust	489,682	For
FRANKLIN STRATEGIC SERIES	461,963	For
Prudential/PGIM	460,752	For
Charles Schwab	456,965	For
Pear Tree Funds	416,700	For
State Street	392,374	For
Jackson National	263,130	For
TIAA	255,251	For
JANUS INVESTMENT FUND	247,291	For
John Hancock	218,680	For
Invesco	217,460	For
SEI	199,796	For
Russell Investments	192,236	For
Bridge Builder Trust	179,717	For
AIG/SunAmerica	150,578	For
Franklin Custodian Funds	150,000	For
Northwestern Mutual	144,818	For
Equitable	123,217	For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

8. To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre- emption right that would otherwise apply.

CAPITAL STRUCTURE

Meeting held 2023-08-03; no official results are on file for this meeting.

Combines 5 wordings of this item as funds reported it.

95% fund support · no official result

FOR 95%

The 126 asset managers below cast 95% of the shares they voted on this item FOR (21,530,185 for, 1,025,609 against).

FOR: 21,530,185 (95.4%)AGAINST: 1,025,609 (4.5%)ABSTAIN: 14,025 (0.1%)

Largest asset managers voting on “To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without ” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Vote
Vanguard	6,038,823	0	For
BlackRock	3,454,854	0	For
Fidelity	1,937,711	0	For
JPMorgan	1,487,735	0	For
Hartford	1,008,293	0	For
Columbia Threadneedle	0	976,745	Against
Dimensional	612,817	0	For
Pacer Funds Trust	489,682	0	For
FRANKLIN STRATEGIC SERIES	461,963	0	For
Prudential/PGIM	460,752	0	For
Charles Schwab	456,965	0	For
Pear Tree Funds	416,700	0	For
State Street	392,374	0	For
Jackson National	263,130	0	For
TIAA	255,251	0	For
JANUS INVESTMENT FUND	247,291	0	For
John Hancock	218,680	0	For
Invesco	217,460	0	For
SEI	199,796	0	For
Russell Investments	192,236	0	For
Bridge Builder Trust	175,088	4,629	For
AIG/SunAmerica	150,578	0	For
Franklin Custodian Funds	150,000	0	For
Northwestern Mutual	144,818	0	For
Equitable	123,217	0	For

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

9. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2023-08-03; no official results are on file for this meeting.

99% fund support · no official result

FOR 99%

The 17 asset managers below cast 99% of the shares they voted on this item FOR (2,405,887 for, 25,316 against).

FOR: 2,405,887 (99.0%)AGAINST: 25,316 (1.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Vote
JPMorgan	1,902,921	0	For
APG Asset Management US Inc.	206,470	0	For
Rokos Capital Management LLP	183,109	0	For
STOREBRAND ASSET MANAGEMENT AS	61,105	0	For
Empower	37,959	0	For
Desjardins Global Asset Management Inc.	0	12,566	Against
NORDEA INVESTMENT MANAGEMENT AB	0	6,914	Against
TD ASSET MANAGEMENT INC	6,614	0	For
Regime de rentes du Mouvement Desjardins	0	5,836	Against
OSSIAM	2,433	0	For
Advisors' Inner Circle Fund III	1,891	0	For
Qtron Investments LLC	1,250	0	For
Echo Street Capital Management LLC	1,245	0	For
TOBAM	716	0	For
CORNELL UNIVERSITY	94	0	For
Convergence Investment Partners, LLC	47	0	For
Edgemoor Investment Advisors, Inc.	33	0	For

10. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2023-08-03; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 4 asset managers below cast 100% of the shares they voted on this item FOR (16,592 for, 0 against).

FOR: 16,592 (100.0%)

Largest asset managers voting on “14A Executive Compensation” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Vote
Granite Investment Partners, LLC	16,564	For
BALLAST ADVISORS LLC	22	For
GRIMES & COMPANY, INC.	6	For
Wallington Asset Management, LLC	0	--

11. To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%

FOR: 49,319,464AGAINST: 4,780,265

JAZZ PHARMACEUTICALS PLC’s own tally for this item (“Proposal 3: to approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement”): 49,319,464 for, 4,780,265 against, per its Form 8-K filed 2024-07-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,214,000 outstanding shares: 78% for, 8% against (86% of the company cast a for/against vote).

The 3 asset managers below cast 13% of the shares they voted on this item FOR (630 for, 4,344 against).

13%AGAINST 87%

FOR: 630 (12.7%)AGAINST: 4,344 (87.3%)

Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive of” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Vote
Freedom Investment Management, Inc.	0	4,344	Against
HOWE & RUSLING INC	600	0	For
MBA Advisors LLC	30	0	For

12. To indicate, on a non-binding advisory basis, the preferred frequency of the advisory vote on the compensation of Jazz Pharmaceuticals plc's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

— fund support · no official result

ONE YEAR 87%13%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 4,344 (87.3%)1 YEAR: 630 (12.7%)

Largest asset managers voting on “To indicate, on a non-binding advisory basis, the preferred frequency of the advisory vote on the compensation” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Freedom Investment Management, Inc.	0	0	0	0	One Year
HOWE & RUSLING INC	0	0	0	0	1 Year
MBA Advisors LLC	0	0	0	0	1 Year

13. Adjourn Meeting

OTHER

Meeting held 2023-08-03; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (39,850 for, 0 against).

FOR: 39,850 (100.0%)

Largest asset managers voting on “Adjourn Meeting” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Empower	37,959	0	0	0	For
Advisors' Inner Circle Fund III	1,891	0	0	0	For

14. Approve KPMG as Auditors and Authorize Board to Fix Their Remuneration

AUDIT-RELATED

Meeting held 2023-08-03; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (39,850 for, 0 against).

FOR: 39,850 (100.0%)

Largest asset managers voting on “Approve KPMG as Auditors and Authorize Board to Fix Their Remuneration” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Empower	37,959	0	0	0	For
Advisors' Inner Circle Fund III	1,891	0	0	0	For

15. Authorise Issue of Equity without Pre-emptive Rights

CAPITAL STRUCTURE

Meeting held 2023-08-03; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (39,850 for, 0 against).

FOR: 39,850 (100.0%)

Largest asset managers voting on “Authorise Issue of Equity without Pre-emptive Rights” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Empower	37,959	0	0	0	For
Advisors' Inner Circle Fund III	1,891	0	0	0	For

Largest JAZZ PHARMACEUTICALS PLC shareholders voting in 2023-2024

Ranked by the number of JAZZ PHARMACEUTICALS PLC shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 63,214,000 shares outstanding at the time of that meeting.

Top JAZZ PHARMACEUTICALS PLC shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	BlackRock	9.96%
2	Vanguard	9.80%
3	Fidelity	4.96%
4	State Street	3.69%
5	LSV ASSET MANAGEMENT	2.59%
6	JPMorgan	2.50%
7	Wellington	2.41%
8	FRANKLIN ADVISERS INC	1.92%
9	Deep Track Capital, LP	1.90%
10	Swedbank Robur Fonder AB	1.69%

Reported JAZZ PHARMACEUTICALS PLC ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

JAZZ PHARMACEUTICALS PLC beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
Vanguard Group	9.34%	13F
BlackRock	8.79%	13F
State Street	3.89%	13F
JPMorgan Chase	2.95%	13F
Seamus Mulligan	1.90%	DEF14A
Renaissance Technologies	1.84%	13F
Geode Capital	1.75%	13F
Franklin Templeton	1.48%	13F
Bruce C. Cozadd	1.42%	DEF14A
Dimensional Fund Advisors	1.30%	13F

Percentages above are of 63,214,000 shares outstanding, as reported by JAZZ PHARMACEUTICALS PLC on its Form 10-K dated 2022-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from JAZZ PHARMACEUTICALS PLC’s 10-K dated 2022-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At JAZZ PHARMACEUTICALS PLC's shareholder meeting held 2023-08-03, in the 2023-2024 proxy season, 556 asset managers reported how they voted in their SEC Form N-PX filings, covering 4,950 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's… — the reporting funds cast 94% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

JAZZ PHARMACEUTICALS PLC proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.